Notably, many IBD risk genes, such as IL23R, JAK1/2, TYK2, and STAT3, participate in IL-22 signaling (32), and the frequency of IL-22–producing type 3 innate lymphoid cells is decreased in CD (33). This evidence concerns the gene JAK1 and inflammatory bowel disease.